Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
Identifieur interne : 000664 ( Main/Exploration ); précédent : 000663; suivant : 000665Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
Auteurs : Harinder Brar [Canada] ; Liat Hogen [Canada] ; Al Covens [Canada]Source :
- Cancer [ 1097-0142 ] ; 2017.
Descripteurs français
- KwdFr :
- Agents colorants, Analyse coût-bénéfice, Années de vie ajustées sur la qualité, Arbres de décision, Biopsie de noeud lymphatique sentinelle (), Biopsie de noeud lymphatique sentinelle (économie), Carcinomes (), Carcinomes (anatomopathologie), Carcinomes (économie), Femelle, Humains, Hystérectomie, Lymphadénectomie (), Lymphadénectomie (économie), Pelvis, Stade de la tumeur (économie), Techniques d'aide à la décision, Technétium, Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (anatomopathologie), Tumeurs du col de l'utérus (économie).
- MESH :
- anatomopathologie : Carcinomes, Tumeurs du col de l'utérus.
- économie : Biopsie de noeud lymphatique sentinelle, Carcinomes, Lymphadénectomie, Stade de la tumeur, Tumeurs du col de l'utérus.
- Agents colorants, Analyse coût-bénéfice, Années de vie ajustées sur la qualité, Arbres de décision, Biopsie de noeud lymphatique sentinelle, Carcinomes, Femelle, Humains, Hystérectomie, Lymphadénectomie, Pelvis, Techniques d'aide à la décision, Technétium, Tumeurs du col de l'utérus.
English descriptors
- KwdEn :
- Carcinoma (economics), Carcinoma (pathology), Carcinoma (surgery), Coloring Agents, Cost-Benefit Analysis, Decision Support Techniques, Decision Trees, Female, Humans, Hysterectomy, Lymph Node Excision (economics), Lymph Node Excision (methods), Neoplasm Staging (economics), Pelvis, Quality-Adjusted Life Years, Sentinel Lymph Node Biopsy (economics), Sentinel Lymph Node Biopsy (methods), Technetium, Uterine Cervical Neoplasms (economics), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (surgery).
- MESH :
- chemical : Coloring Agents, Technetium.
- economics : Carcinoma, Lymph Node Excision, Neoplasm Staging, Sentinel Lymph Node Biopsy, Uterine Cervical Neoplasms.
- methods : Lymph Node Excision, Sentinel Lymph Node Biopsy.
- pathology : Carcinoma, Uterine Cervical Neoplasms.
- surgery : Carcinoma, Uterine Cervical Neoplasms.
- Cost-Benefit Analysis, Decision Support Techniques, Decision Trees, Female, Humans, Hysterectomy, Pelvis, Quality-Adjusted Life Years.
Abstract
The objective of this study was to determine the cost-effectiveness of radical hysterectomy (RH) and sentinel lymph node biopsy (SLNB) for the management of early-stage cervical cancer (stage IA2-IB1).
DOI: 10.1002/cncr.30509
PubMed: 28117888
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000403
- to stream PubMed, to step Curation: 000403
- to stream PubMed, to step Checkpoint: 000403
- to stream Ncbi, to step Merge: 008C46
- to stream Ncbi, to step Curation: 008C46
- to stream Ncbi, to step Checkpoint: 008C46
- to stream Main, to step Merge: 000665
- to stream Main, to step Curation: 000664
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.</title><author><name sortKey="Brar, Harinder" sort="Brar, Harinder" uniqKey="Brar H" first="Harinder" last="Brar">Harinder Brar</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hogen, Liat" sort="Hogen, Liat" uniqKey="Hogen L" first="Liat" last="Hogen">Liat Hogen</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28117888</idno><idno type="pmid">28117888</idno><idno type="doi">10.1002/cncr.30509</idno><idno type="wicri:Area/PubMed/Corpus">000403</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000403</idno><idno type="wicri:Area/PubMed/Curation">000403</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000403</idno><idno type="wicri:Area/PubMed/Checkpoint">000403</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000403</idno><idno type="wicri:Area/Ncbi/Merge">008C46</idno><idno type="wicri:Area/Ncbi/Curation">008C46</idno><idno type="wicri:Area/Ncbi/Checkpoint">008C46</idno><idno type="wicri:Area/Main/Merge">000665</idno><idno type="wicri:Area/Main/Curation">000664</idno><idno type="wicri:Area/Main/Exploration">000664</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.</title><author><name sortKey="Brar, Harinder" sort="Brar, Harinder" uniqKey="Brar H" first="Harinder" last="Brar">Harinder Brar</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Hogen, Liat" sort="Hogen, Liat" uniqKey="Hogen L" first="Liat" last="Hogen">Liat Hogen</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></analytic><series><title level="j">Cancer</title><idno type="eISSN">1097-0142</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carcinoma (economics)</term><term>Carcinoma (pathology)</term><term>Carcinoma (surgery)</term><term>Coloring Agents</term><term>Cost-Benefit Analysis</term><term>Decision Support Techniques</term><term>Decision Trees</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Lymph Node Excision (economics)</term><term>Lymph Node Excision (methods)</term><term>Neoplasm Staging (economics)</term><term>Pelvis</term><term>Quality-Adjusted Life Years</term><term>Sentinel Lymph Node Biopsy (economics)</term><term>Sentinel Lymph Node Biopsy (methods)</term><term>Technetium</term><term>Uterine Cervical Neoplasms (economics)</term><term>Uterine Cervical Neoplasms (pathology)</term><term>Uterine Cervical Neoplasms (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents colorants</term><term>Analyse coût-bénéfice</term><term>Années de vie ajustées sur la qualité</term><term>Arbres de décision</term><term>Biopsie de noeud lymphatique sentinelle ()</term><term>Biopsie de noeud lymphatique sentinelle (économie)</term><term>Carcinomes ()</term><term>Carcinomes (anatomopathologie)</term><term>Carcinomes (économie)</term><term>Femelle</term><term>Humains</term><term>Hystérectomie</term><term>Lymphadénectomie ()</term><term>Lymphadénectomie (économie)</term><term>Pelvis</term><term>Stade de la tumeur (économie)</term><term>Techniques d'aide à la décision</term><term>Technétium</term><term>Tumeurs du col de l'utérus ()</term><term>Tumeurs du col de l'utérus (anatomopathologie)</term><term>Tumeurs du col de l'utérus (économie)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term><term>Technetium</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinomes</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Carcinoma</term><term>Lymph Node Excision</term><term>Neoplasm Staging</term><term>Sentinel Lymph Node Biopsy</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term><term>Carcinomes</term><term>Lymphadénectomie</term><term>Stade de la tumeur</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cost-Benefit Analysis</term><term>Decision Support Techniques</term><term>Decision Trees</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Pelvis</term><term>Quality-Adjusted Life Years</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Agents colorants</term><term>Analyse coût-bénéfice</term><term>Années de vie ajustées sur la qualité</term><term>Arbres de décision</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Carcinomes</term><term>Femelle</term><term>Humains</term><term>Hystérectomie</term><term>Lymphadénectomie</term><term>Pelvis</term><term>Techniques d'aide à la décision</term><term>Technétium</term><term>Tumeurs du col de l'utérus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to determine the cost-effectiveness of radical hysterectomy (RH) and sentinel lymph node biopsy (SLNB) for the management of early-stage cervical cancer (stage IA2-IB1).</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><region name="Ontario"><name sortKey="Brar, Harinder" sort="Brar, Harinder" uniqKey="Brar H" first="Harinder" last="Brar">Harinder Brar</name></region><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name><name sortKey="Hogen, Liat" sort="Hogen, Liat" uniqKey="Hogen L" first="Liat" last="Hogen">Liat Hogen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000664 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000664 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28117888
|texte= Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28117888" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |